Register Login

Guardant Health Inc (GH)

Monroe Terilyn J. 🟡 adjusted position in 7.5K shares (2 derivative) of Guardant Health, Inc. (GH) at $102.14 Transaction Date: Jan 01, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 12:18 a.m.

    🔍 Monroe Terilyn J. (Executive)

    Company: Guardant Health, Inc. (GH)

    Report Date: 2026-01-01

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 17,555
    • Total shares sold: 25,079

    Detailed Transactions and Holdings:

    • Acquired 14,896 shares of Common Stock (Direct)
      Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,886.00 | transaction_form_type: 4
    • Acquired 2,659 shares of Common Stock (Direct)
      Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 38,545.00 | transaction_form_type: 4
    • Sold 7,524 shares of Common Stock at $102.14 per share (Direct)
      Date: 2026-01-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 31,021.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 14,896 shares of Performance-Based Restricted Stock Units (Derivative)
      Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,898.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Sold 2,659 shares of Restricted Stock Units (Derivative)
      Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 18,615.00 | transaction_form_type: 4 | Footnotes: F4, F3

    Footnotes:

    • F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
    • F2: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027.
    • F3: Not applicable for Restricted Stock Units.
    • F4: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
    • REMARKS: Table I includes 70 shares acquired under Guardant Health's Employee Stock Purchase Plan on 11/14/2025.

Search

News categories